Sulfonamide-based ring-fused analogues for CAN508 as novel carbonic anhydrase inhibitors endowed with antitumor activity: Design, synthesis, and in vitro biological evaluation

2020 ◽  
Vol 189 ◽  
pp. 112019 ◽  
Author(s):  
Mohamed A. Said ◽  
Wagdy M. Eldehna ◽  
Alessio Nocentini ◽  
Samar H. Fahim ◽  
Alessandro Bonardi ◽  
...  
2020 ◽  
Vol 28 (15) ◽  
pp. 115586
Author(s):  
Baijayantimala Swain ◽  
Andrea Angeli ◽  
Priti Singh ◽  
Claudiu T. Supuran ◽  
Mohammed Arifuddin

Molecules ◽  
2019 ◽  
Vol 25 (1) ◽  
pp. 10 ◽  
Author(s):  
Hehua Xiong ◽  
Jianxin Cheng ◽  
Jianqing Zhang ◽  
Qian Zhang ◽  
Zhen Xiao ◽  
...  

A series of 4-(pyridin-4-yloxy)benzamide derivatives containing a 1,2,3-triazole fragment were designed, synthesized, and their inhibitory activity against A549, HeLa, and MCF-7 cancer cell lines was evaluated. Most compounds exhibited moderate to potent antitumor activity against the three cell lines. Among them, the promising compound B26 showed stronger inhibitory activity than Golvatinib, with IC50 values of 3.22, 4.33, and 5.82 μM against A549, HeLa, and MCF-7 cell lines, respectively. The structure–activity relationships (SARs) demonstrated that the modification of the terminal benzene ring with a single electron-withdrawing substituent (fluorine atom) and the introduction of a pyridine amide chain with a strong hydrophilic group (morpholine) to the hinge region greatly improved the antitumor activity. Meanwhile, the optimal compound B26 showed potent biological activity in some pharmacological experiments in vitro, such as cell morphology study, dose-dependent test, kinase activity assay, and cell cycle experiment. Finally, the molecular docking simulation was performed to further explore the binding mode of compound B26 with c-Met.


2018 ◽  
Vol 156 ◽  
pp. 430-443 ◽  
Author(s):  
Chandra Bhushan Mishra ◽  
Shikha Kumari ◽  
Andrea Angeli ◽  
Silvia Bua ◽  
Martina Buonanno ◽  
...  

2011 ◽  
Vol 54 (5) ◽  
pp. 1481-1489 ◽  
Author(s):  
Marie Lopez ◽  
Jonathan Trajkovic ◽  
Laurent F. Bornaghi ◽  
Alessio Innocenti ◽  
Daniela Vullo ◽  
...  

2014 ◽  
Vol 5 (7) ◽  
pp. 793-796 ◽  
Author(s):  
Jayashree Pichake ◽  
Prashant S. Kharkar ◽  
Mariangela Ceruso ◽  
Claudiu T. Supuran ◽  
Mrunmayee P. Toraskar

Molecules ◽  
2020 ◽  
Vol 25 (5) ◽  
pp. 1162
Author(s):  
Lintao Wu ◽  
Yuting Yang ◽  
Zhijun Wang ◽  
Xi Wu ◽  
Feng Su ◽  
...  

A series of benzimidazole-derived chalcones containing aromatic amide substituent were designed and synthesized. All of the chalcone compounds were tested for their in vitro antitumor activity against human cancer cell lines (HCT116, HepG2, A549, and CRL-5908). The antiproliferative activity of compounds 3, 6, 9, 14, 15, 16 against HCT116 cells was significantly better than that that of 5-Fluorouracil (IC50: 94.63 µM). The antitumor activity of these compounds showed obvious differences between the wild type HCT116 and mutant HCT116 (TP53−/−) cells. A preliminary mechanistic study suggested that these compounds act by upregulating the expression of TP53 protein in tumor cells without inhibiting the MDM2-TP53 interaction.


2019 ◽  
Vol 10 (8) ◽  
pp. 1205-1210 ◽  
Author(s):  
Adèle Larcher ◽  
Alessio Nocentini ◽  
Claudiu T. Supuran ◽  
Jean-Yves Winum ◽  
Arie van der Lee ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document